Biomarkers · 2012 · 13 citations · 21 references
Life SciencesBiochemistryOncologyClinical BiochemistryMass Spectrometric AnalysisProteomicsClinical ProteomicsMass Spectrometry-based ProteomicsPeptide AnalysisPeptide IdentificationProteomic BiomarkersProteomic ProfilingHigh-sensitivity AssaysMagnetic Bead-based ExtractionMass Spectrometry-based Protein IdentificationPeptide Marker AnalysisPeptide Mass SpectrometryPeptide-mass FingerprintingProteomic IdentificationReversed-phase Chromatography
CONTEXT: Smoking is the major contributor of lung cancer (LC), which accounts for millions of death. OBJECTIVE: This study focused on the correlation between the proteomic profiling of LC patients, and healthy nonsmokers and smokers. METHOD: Pattern-based peptide profiling of 186 plasma samples was performed through reversed-phase chromatography-18 magnetic bead fractionation coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis and resulted data were evaluated statistically by ClinProTool. RESULTS: Marker peaks at m/z 1760, 5773, 5851, 2940, and 7172 were found with an excellent statistical figure. CONCLUSION: Selected marker peaks can be served as a differentiated tool of LC patients with high sensitivity and specificity.
21
Smoking and Lung Cancer: The Role of Inflammation
Tonya C. Walser, Xiaoyan Cui, Jane Yanagawa et al. · Proceedings of the American Thoracic Society · 2008 · 389 citations
Medicine, Cancer Biology, Oncology +17
Smoking and lung cancer: An overview
Loeb La, Ernster Vl, Kenneth E. Warner et al. · Lung Cancer · 1985 · 354 citations